About us

Biotech Newswire (formerly B3C Newswire) was founded more than 20 years ago by Dr. Sabine Duntze, a biotech marketing and PR specialist with a strong scientific background. Sabine spent many years conducting research at the Pasteur Institute in Paris (supported by a Boehringer Ingelheim grant) and at the Max Planck Institute for Immunobiology in Freiburg, Germany. During this time, she recognized that no dedicated newswire existed for biotech, medtech, and life science companies, and created Biotech Newswire to fill that gap.

Today, Biotech Newswire provides unmatched reach across global biotech, pharma, medtech, and life science trade media. Our distribution network includes highly targeted vertical channels and key opinion leaders (KOLs). Every media outlet and editorial contact has been hand-selected and continuously updated over more than two decades. Press releases are distributed according to each editor’s preferences to ensure maximum relevance and visibility.

We focus on earned media coverage, the most trusted and credible form of communication. Earned media means that we send your press release directly to editors and journalists who choose what to publish based on relevance and news value. In contrast, many generic newswires rely on owned media distribution - automatically placing content on hundreds of websites they control. Only earned media provides third-party credibility, higher trust, and true amplification through specialized readership. This is why earned media is essential for biotech, medtech, and life science companies seeking meaningful visibility for their products, research, and services.